A secret that hides Vor Biopharma Inc’s strength (NASDAQ:VOR)

Stocks of Vor Biopharma Inc (NASDAQ:VOR) traded higher last session on Wall Street, up 51.55% to $1.27.

VOR stock price is now 48.52% away from the 50-day moving average and 9.05% away from the 200-day moving average. The market capitalization of the company currently stands at $132.18M.

With the price target of $18, Wedbush recently initiated with Outperform rating for Vor Biopharma Inc (NASDAQ: VOR). On April 27, 2022, Goldman recently initiated its ‘Neutral’ rating on the stock quoting a target price of $6, while ‘H.C. Wainwright’ rates the stock as ‘Buy’

In other news, EYAL ATTAR , Officer bought 10,334 shares of the company’s stock on Dec 27 ’24. The stock was bought for $8,660 at an average price of $0.84. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 03 ’24, CHIEF MEDICAL OFFICER Attar Eyal C. sold 14,645 shares of the business’s stock. A total of $20,357 was realized by selling the stock at an average price of $1.39. This leaves the insider owning 96,063 shares of the company worth $0.12 million. A total of 12.81% of the company’s stock is owned by insiders.

During the past 12 months, Vor Biopharma Inc has had a low of $0.63 and a high of $3.14. As of last week, the company has a debt-to-equity ratio of 0.45, a current ratio of 4.69, and a quick ratio of 4.69. The fifty day moving average price for VOR is $0.85512 and a two-hundred day moving average price translates $1.164635 for the stock.

The latest earnings results from Vor Biopharma Inc (NASDAQ: VOR) was released for 2024-06-30.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.